Insights

Acquisition Context InfaCare was acquired by Mallinckrodt in 2017 for 80 million, indicating strategic value to larger specialty pharma players and potential continuity in product development and support for neonatal and pediatric portfolios.

Niche Focus Specialty focus on neonatal and pediatric populations suggests strong pediatric formulary needs, regulatory considerations, and potential for partnerships with hospitals, pediatric clinics, and NICUs seeking specialized therapies.

Founding Scale Current headcount is small (2-10 employees) with revenue indicating early-stage profitability; opportunities exist to engage around manufacturing scale-up, regulatory submissions, and commercialization capabilities.

Tech & Digital Existing tech stack includes WordPress and analytics tools, signaling readiness for digital outreach, product education campaigns, and customer relationship activities targeting healthcare providers and payers.

Funding Leverage Raised substantial funding (funding of 76M) and prior acquisition by a global specialty company imply potential for partnership discussions, co-development, or license-out opportunities to leverage larger distribution networks.

Similar companies to InfaCare Pharmaceuticals

InfaCare Pharmaceuticals Tech Stack

InfaCare Pharmaceuticals uses 7 technology products and services including WordPress, Font Awesome, Google Fonts API, and more. Explore InfaCare Pharmaceuticals's tech stack below.

  • Content Management System
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics

InfaCare Pharmaceuticals's Email Address Formats

InfaCare Pharmaceuticals uses at least 1 email format:
InfaCare Pharmaceuticals Email FormatsExamplePercentage
FLast@infacare.comJDoe@infacare.com
100%

Frequently Asked Questions

What is InfaCare Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact InfaCare Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is InfaCare Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
InfaCare Pharmaceuticals's official website is infacare.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does InfaCare Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of September 2026, InfaCare Pharmaceuticals's annual revenue is estimated to be $1M - $10M.

What is InfaCare Pharmaceuticals's SIC code and NAICS code?

Minus sign iconPlus sign icon
InfaCare Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does InfaCare Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of September 2026, InfaCare Pharmaceuticals has approximately 7 employees across 1 continents, including North America. Key team members include Manager, Cmc Regulatory Affairs: S. R. Explore InfaCare Pharmaceuticals's employee directory with LeadIQ.

What industry does InfaCare Pharmaceuticals belong to?

Minus sign iconPlus sign icon
InfaCare Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does InfaCare Pharmaceuticals use?

Minus sign iconPlus sign icon
InfaCare Pharmaceuticals's tech stack includes WordPress, Font Awesome, Google Fonts API, Twemoji, jQuery, PHP and Google Analytics.

What is InfaCare Pharmaceuticals's email format?

Minus sign iconPlus sign icon
InfaCare Pharmaceuticals's email format typically follows the pattern of FLast@infacare.com. Find more InfaCare Pharmaceuticals email formats with LeadIQ.

How much funding has InfaCare Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of September 2026, InfaCare Pharmaceuticals has raised $76M in funding. The last funding round occurred on Jul 08, 2015 for $12M.
InfaCare Pharmaceuticals logo

InfaCare Pharmaceuticals

Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees

InfaCare Pharmaceuticals operates as a specialty pharmaceutical company focused on developing and commercializing proprietary medicines for neonatal and pediatric patients. It is based in Trevose, Pennsylvania, and participates in the pharmaceutical manufacturing industry with a small staff. The company concentrates on therapies designed for newborns and young children, aiming to address their specific medical needs.

In September 2017, Mallinckrodt completed the acquisition of InfaCare, marking a significant development in its corporate history. The available information describes InfaCare as a firm dedicated to bringing pediatric and neonatal pharmaceuticals to market, reflecting its niche focus within the broader pharmaceutical sector.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $76M

    InfaCare Pharmaceuticals has raised a total of $76M of funding over 6 rounds. Their latest funding round was raised on Jul 08, 2015 in the amount of $12M as a Venture Round.

  • $1M - $10M

    InfaCare Pharmaceuticals's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.